Adenovirus-mediated suicide gene therapy for experimental bladder cancer
Authors:
- Scott A. BerkmanSBScott A. Berkman
- Shu-Hsia ChenSCShu-Hsia Chen
- Andreas BlockABAndreas Block
- Truong D. DangTDTruong D. Dang
- Michael W. KattanMKMichael W. Kattan
- Thomas M. WheelerTWThomas M. Wheeler
- David R. RowleyDRDavid R. Rowley
- Savio L.C. WooSWSavio L.C. Woo
- Seth P. LernerSLSeth P. Lerner
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Adenoviral - P53 Gene Transfer to Orthotopic and Peritoneal Murine Bladder CancerJournal of Urology, 1996
- Gene therapy for urologic cancerUrology, 1994
- Gene therapy: adenovirus vectorsCurrent Opinion in Genetics & Development, 1993
- The Basic Science of Gene TherapyScience, 1993
- Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells.Journal of Experimental Medicine, 1993
- In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain TumorsScience, 1992
- Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapseCancer, 1989
- Antiviral Activity and Mechanism of Action of GanciclovirClinical Infectious Diseases, 1988
- Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study.Journal of Clinical Oncology, 1985
- A Review of Adenoviruses in the Etiology of Acute Hemorrhagic CystitisJournal of Urology, 1976